Skip to main content
Top

Comprehensive assessment of postoperative quality of life and risk factors after robot-assisted radical prostatectomy using the EPIC questionnaire

  • 05-03-2026
  • Original Article
Published in:

Abstract

Background

Robot-assisted radical prostatectomy (RARP) is a standard treatment for localized prostate cancer. This procedure provides favorable oncologic outcomes but poses functional challenges, particularly urinary incontinence and sexual dysfunction, that can affect patients’ quality of life (QOL). This study examined predictive factors for postoperative recovery of urinary, sexual, and bowel functions using the Expanded Prostate Cancer Index Composite (EPIC) questionnaire.

Methods

This single-center retrospective study included 279 patients who underwent RARP between 2011 and 2023. Health-related QOL was assessed preoperatively and up to 18 months postoperatively using the EPIC questionnaire. Recovery was defined as achieving ≥90% of baseline scores at 18 months. Firth’s penalized logistic regression and baseline-adjusted analyses were performed to identify factors associated with poor recovery.

Results

Urinary function improved gradually, but 39.8% of patients showed suboptimal recovery at 18 months. In multivariable Firth’s penalized logistic regression analysis, longer console time was independently associated with poor urinary incontinence recovery (OR 2.15, 95% CI 1.14–4.17). Ratio-based analyses suggested age-related differences in sexual recovery; however, baseline-adjusted analyses demonstrated a dissociation between postoperative sexual function and sexual bother. Nerve-sparing status was not independently associated with urinary and sexual recovery. Bowel function remained stable.

Conclusion

Longer console time was independently associated with poorer recovery of urinary continence after RARP, likely reflecting surgical complexity rather than a direct causal effect. Baseline-adjusted analyses revealed a dissociation between postoperative sexual function and sexual bother, underscoring the limitations of function-based QOL assessment and the need for patient-centered counseling and shared decision-making in RARP.
Title
Comprehensive assessment of postoperative quality of life and risk factors after robot-assisted radical prostatectomy using the EPIC questionnaire
Authors
Toru Sakatani
Kimihiko Masui
Toshihiro Magaribuchi
Akihiro Hamada
Kei Mizuno
Takayuki Sumiyoshi
Yuki Kita
Takashi Kobayashi
Takayuki Goto
Publication date
05-03-2026
Publisher
Springer Nature Singapore
Published in
International Journal of Clinical Oncology / Issue 4/2026
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-026-02995-3
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.

Case simulations: Biomarker-driven management of NSCLC (Link opens in a new window)

Do you want to assess your biomarker testing skills and management decisions? Use these simulation-based case studies based on realistic NSCLC scenarios to do so in a practical and secure environment.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
COMMISSIONED

How-to guide for healthcare professionals: understanding genomic reports

This educational activity was initiated, funded and co-developed by Boehringer Ingelheim and is intended for healthcare professionals in the UK and Ireland only. 

Genomic testing helps inform cancer diagnosis, prognosis, and treatment. A genomic report is generated by the laboratory carrying out next-generation sequencing to analyze biopsy samples. Access this educational microsite to learn more about typical genomic report content and how to interpret test results for patients with cancer.

NP-GB-106631 | Jan 2026

Commissioned by:
  • Boehringer Ingelheim
Learn more
Image Credits
Biomarker-driven management of NSCLC logo/© Springer Health+ IME, DNA double helix structure on a purple background/© 2025 Adobe